BIO Double Helix Sponsor
Sponsors

Company Profile

Tissue Genetics, Inc

Diagnostics
Cancer
Drug Discovery

12635 E Montview Blvd Suite 224
Aurora, CO 80045
USA
http://www.tissuegenetics.com/ 		Incorporated in 2006
4 Employees 		Privately Held

This Year's Highlights

  • We've developed a monoclonal antibody that differentiates Hereditary from Sporadic cancers, both Breast and Ovarian.
  • We've developed a monoclonal antibody that may predict response to PARP inhibitor therapy in both Breast and Ovarian.
  • Received an award of $176,000 through the State of Colorado and the University of Colorado toward the research of these tests.

Anticipated Highlights

  • Award of first of 3 STTR grant funds in late 2007-early 2008
  • Award of second of 3 STTR grant funds in mid 2008
  • Operation of in house diagnostic testing to begin generating revenue by late 2007

Corporate Mission

Tissue Genetics is a predictive medicine company working to tailor treatment to need. Our unique business model pairs the development of proprietary, tissue-based diagnostic tests with the complimentary therapy. Thus specifically treating patients based on their diagnostic test results.